Literature DB >> 23729940

Differences in insulin secretion and sensitivity in short-sleep insomnia.

Kaveeta P Vasisht1, Lynn E Kessler, John N Booth, Jacqueline G Imperial, Plamen D Penev.   

Abstract

OBJECTIVE: Short-sleep insomnia is associated with increased risk of diabetes. The role of altered insulin secretion and action in this association is poorly understood.
DESIGN: Observational study.
SETTING: Academic clinical research center. PARTICIPANTS: Nondiabetic individuals with insomnia (mean [standard deviation] age 48 [9] y, body mass index 25.6 [3.9] kg/m(2)) with ≤ 6 h (short sleep, n = 14) and > 6 h of sleep (n = 14) during overnight laboratory polysomnography. MEASUREMENTS AND
RESULTS: Standard oral glucose testing was used to assess glucose tolerance, beta-cell function (homeostasis model assessment [HOMA-B]; second-phase insulin secretion) and insulin resistance (HOMA-IR; insulin sensitivity index). There was no significant difference in hemoglobin A1C and fasting or 2-h blood glucose concentrations between sleep groups. Short-sleep insomnia sufferers had lower fasting and postchallenge serum insulin concentrations associated with lower estimates of fasting and glucose-stimulated insulin secretion, and increased insulin sensitivity.
CONCLUSIONS: Individuals with short-sleep insomnia appear to have higher indices of systemic insulin sensitivity and secrete less insulin without changes in overall glucose tolerance.

Entities:  

Keywords:  Decreased quantity and quality of sleep; oral glucose tolerance; pancreatic beta-cell function; systemic insulin resistance

Mesh:

Substances:

Year:  2013        PMID: 23729940      PMCID: PMC3649837          DOI: 10.5665/sleep.2734

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  15 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

2.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

3.  Self-reported sleep quality is associated with the metabolic syndrome.

Authors:  J Richard Jennings; Matthew F Muldoon; Martica Hall; Daniel J Buysse; Stephen B Manuck
Journal:  Sleep       Date:  2007-02       Impact factor: 5.849

Review 4.  Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Francesco P Cappuccio; Lanfranco D'Elia; Pasquale Strazzullo; Michelle A Miller
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

Review 5.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 6.  Hyperarousal and insomnia: state of the science.

Authors:  Michael H Bonnet; Donna L Arand
Journal:  Sleep Med Rev       Date:  2009-07-28       Impact factor: 11.609

7.  Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004).

Authors:  Rodolfo Valdez; Paula W Yoon; Tiebin Liu; Muin J Khoury
Journal:  Diabetes Care       Date:  2007-07-18       Impact factor: 19.112

8.  Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity.

Authors:  Edward C Suarez
Journal:  Brain Behav Immun       Date:  2008-03-06       Impact factor: 7.217

9.  Effects of sleep restriction on glucose control and insulin secretion during diet-induced weight loss.

Authors:  Arlet V Nedeltcheva; Jacqueline G Imperial; Plamen D Penev
Journal:  Obesity (Silver Spring)       Date:  2012-04-19       Impact factor: 5.002

10.  Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study.

Authors:  Alexandros N Vgontzas; Duanping Liao; Slobodanka Pejovic; Susan Calhoun; Maria Karataraki; Edward O Bixler
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 19.112

View more
  11 in total

1.  Objective measures are useful in subtyping chronic insomnia.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

2.  Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study.

Authors:  Suzanne M Bertisch; Benjamin D Pollock; Murray A Mittleman; Daniel J Buysse; Lydia A Bazzano; Daniel J Gottlieb; Susan Redline
Journal:  Sleep       Date:  2018-06-01       Impact factor: 5.849

3.  Association of insomnia and short sleep duration, alone or with comorbid obstructive sleep apnea, and the risk of chronic kidney disease.

Authors:  Andrew E Beaudin; Jill K Raneri; Sofia Ahmed; A J Hirsch Allen; Andrhea Nocon; Teresa Gomes; Simon Gakwaya; Frédéric Sériès; John R Kimoff; Robert Skomro; Najib Ayas; Patrick J Hanly
Journal:  Sleep       Date:  2022-07-11       Impact factor: 6.313

Review 4.  Metabolic consequences of sleep and circadian disorders.

Authors:  Christopher M Depner; Ellen R Stothard; Kenneth P Wright
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

5.  Insomnia with objective short sleep duration is associated with cognitive impairment: a first look at cardiometabolic contributors to brain health.

Authors:  Julio Fernandez-Mendoza; Fan He; Kristina Puzino; Gregory Amatrudo; Susan Calhoun; Duanping Liao; Alexandros N Vgontzas; Edward Bixler
Journal:  Sleep       Date:  2021-01-21       Impact factor: 5.849

6.  Poor Sleep Quality is Associated with Insulin Resistance in Postmenopausal Women With and Without Metabolic Syndrome.

Authors:  Christopher E Kline; Martica H Hall; Daniel J Buysse; Conrad P Earnest; Timothy S Church
Journal:  Metab Syndr Relat Disord       Date:  2018-03-20       Impact factor: 1.894

7.  Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

Authors:  Orfeu M Buxton; Milena K Pavlova; Shawn P O'Connor; Wei Wang; John W Winkelman
Journal:  Nat Sci Sleep       Date:  2017-07-18

8.  Interplay of Objective Sleep Duration and Cardiovascular and Cerebrovascular Diseases on Cause-Specific Mortality.

Authors:  Julio Fernandez-Mendoza; Fan He; Alexandros N Vgontzas; Duanping Liao; Edward O Bixler
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 5.501

9.  Understanding insomnia as systemic disease.

Authors:  Seokho Yun; Sohye Jo
Journal:  Yeungnam Univ J Med       Date:  2021-09-13

10.  Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration.

Authors:  Julio Fernandez-Mendoza; Fan He; Caitlin LaGrotte; Alexandros N Vgontzas; Duanping Liao; Edward O Bixler
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.